Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Under-use of Radiotherapy in Stage III Bronchioaveolar Lung Cancer and Socio-economic Disparities in Cause Specific Survival: a Population Study

  • Published : 2014.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study used the receiver operating characteristic curve (ROC) to analyze Surveillance, Epidemiology and End Results (SEER) bronchioaveolar carcinoma data to identify predictive models and potential disparity in outcomes. Materials and Methods: Socio-economic, staging and treatment factors were assessed. For the risk modeling, each factor was fitted by a Generalized Linear Model to predict cause specific survival. The area under the ROC was computed. Similar strata were combined to construct the most parsimonious models. A random sampling algorithm was used to estimate modeling errors. Risk of cause specific death was computed for the predictors for comparison. Results: There were 7,309 patients included in this study. The mean follow up time (S.D.) was 24.2 (20) months. Female patients outnumbered male ones 3:2. The mean (S.D.) age was 70.1 (10.6) years. Stage was the most predictive factor of outcome (ROC area of 0.76). After optimization, several strata were fused, with a comparable ROC area of 0.75. There was a 4% additional risk of death associated with lower county family income, African American race, rural residency and lower than 25% county college graduate. Radiotherapy had not been used in 2/3 of patients with stage III disease. Conclusions: There are socio-economic disparities in cause specific survival. Under-use of radiotherapy may have contributed to poor outcome. Improving education, access and rates of radiotherapy use may improve outcome.

Keywords

References

  1. Bhatia S (2011). Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer, 56, 994-1002. https://doi.org/10.1002/pbc.23078
  2. Cheung MC, Zhuge Y, Yang R, et al (2010). Incidence and outcomes of extremity soft-tissue sarcomas in children. J Surg Res, 163, 282-9. https://doi.org/10.1016/j.jss.2010.04.033
  3. Cheung R (2012). Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis. Asian Pac J Cancer Prev, 13, 4587-91. https://doi.org/10.7314/APJCP.2012.13.9.4587
  4. Cheung R, Altschuler MD, D'Amico AV, et al (2001). ROC-optimization may improve risk stratification of prostate cancer patients. Urology, 57, 286-90. https://doi.org/10.1016/S0090-4295(00)00911-0
  5. Cheung R, Altschuler MD, D'Amico AV, et al (2001). Using the receiver operator characteristic curve to select pretreatment and pathologic predictors for early and late post-prostatectomy PSA failure. Urology, 58, 400-5. https://doi.org/10.1016/S0090-4295(01)01209-2
  6. D'Amico AV, Desjardin A, Chung A, et al (1998). Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer, 82, 1887-96. https://doi.org/10.1002/(SICI)1097-0142(19980515)82:10<1887::AID-CNCR11>3.0.CO;2-P
  7. Downing S, Ahuja N, Oyetunji TA, Chang D, Frederick WA (2010). Disparity in limb-salvage surgery among sarcoma patients. Am J Surg, 199, 549-53. https://doi.org/10.1016/j.amjsurg.2009.12.003
  8. Garfield DH, Franklin WA (2008). A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy. Cancer, 113, 1107-8. https://doi.org/10.1002/cncr.23662
  9. Gross CP, Smith BD, Wolf E, Andersen M (2008). Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer, 112, 900-8. https://doi.org/10.1002/cncr.23228
  10. Hanley JA, McNeil BJ (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29-36. https://doi.org/10.1148/radiology.143.1.7063747
  11. Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B (1995). Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol, 13, 93-100. https://doi.org/10.1200/JCO.1995.13.1.93
  12. Hasan S, Mujahid H, Yousef M, Chisholm R (2004). Bronchioloalveolar carcinoma in African Americans. J Natl Med Assoc, 96, 1193-8.
  13. Lund MJ, Brawley OP, Ward KC, et al (2008). Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat, 109, 545-57. https://doi.org/10.1007/s10549-007-9675-8
  14. Mantovani C, Giaj Levra N, Filippi AR, et al (2012). Postoperative radiotherapy for patients with completely resected pathologic N2 non-small-cell lung cancer: a retrospective analysis. Clin Lung Cancer, 14, 194-9.
  15. Martinez SR, Beal SH, Chen SL, et al (2010). Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys, 78, 787-92. https://doi.org/10.1016/j.ijrobp.2009.08.080
  16. Martinez SR, Tseng WH, Canter RJ, et al (2012). Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer, 118, 196-204. https://doi.org/10.1002/cncr.26231
  17. McDowell HP, Foot AB, Ellershaw C, et al (2010). Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. Eur J Cancer, 46, 1588-95. https://doi.org/10.1016/j.ejca.2010.02.051
  18. Ognjanovic S, Linabery AM, Charbonneau B, Ross JA (2009). Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer, 115, 4218-26. https://doi.org/10.1002/cncr.24465
  19. Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman G (2010). Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. J Clin Oncol, 28, 5011-6. https://doi.org/10.1200/JCO.2010.31.2603
  20. Perez EA, Kassira N, Cheung MC, et al (2011). Rhabdomyosarcoma in children: a SEER population based study. J Surg Res, 170, 243-51. https://doi.org/10.1016/j.jss.2011.03.001
  21. Price A (2012). Emerging developments of chemoradiotherapy in stage III NSCLC. Nat Rev Clin Oncol, 9, 591-8. https://doi.org/10.1038/nrclinonc.2012.135
  22. Raz DJ, Jablons DM (2006). Bronchioloalveolar carcinoma is not associated with younger age at diagnosis: an analysis of the SEER database. J Thorac Oncol, 1, 339-43. https://doi.org/10.1097/01243894-200605000-00013
  23. Riquet M, Foucault C, Berna P, et al (2006). Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann Thorac Surg, 81, 1988-995. https://doi.org/10.1016/j.athoracsur.2006.01.021
  24. Saeed AM, Toonkel R, Glassberg MK, et al (2012). The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival: An analysis of the Survival, Epidemiology, and End Results database. Cancer, 119, 1285-6.
  25. Schlichting JA, Soliman AS, Schairer C, et al (2012). Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiol Biomarkers Prev, 21, 155-65. https://doi.org/10.1158/1055-9965.EPI-11-0833
  26. Shavers VL, Harlan LC, Stevens JL (2003). Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer, 97, 134-47. https://doi.org/10.1002/cncr.11051
  27. Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A (2009). Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol, 27, 3391-7. https://doi.org/10.1200/JCO.2008.19.7483
  28. Varlotto JM, Flickinger JC, Recht A, Nikolov MC, DeCamp MM (2008). A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy. Cancer, 112, 1547-54. https://doi.org/10.1002/cncr.23289
  29. Wampler NS, Lash TL, Silliman RA, Heeren TC (2005). Breast cancer survival of American Indian/Alaska Native women, 1973-1996. Soz Praventivmed, 50, 230-7. https://doi.org/10.1007/s00038-004-4020-6
  30. Yao N, Lengerich EJ, Hillemeier MM (2012). Breast cancer mortality in Appalachia: reversing patterns of disparity over time. J Health Care Poor Underserved, 23, 715-25. https://doi.org/10.1353/hpu.2012.0043

Cited by

  1. Analysis of SEER Adenosquamous Carcinoma Data to Identify Cause Specific Survival Predictors and Socioeconomic Disparities vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.347
  2. Analysis of SEER Glassy Cell Carcinoma Data: Underuse of Radiotherapy and Predicators of Cause Specific Survival vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.353